Literature DB >> 1480143

L-propionylcarnitine and myocardial performance in stunned porcine myocardium.

L M Sassen1, D J Duncker, A Hogendoorn, E O McFalls, R Krams, K Bezstarosti, J M Lamers, P D Verdouw.   

Abstract

Recently, we showed that L-propionylcarnitine did not affect recovery of regional contractile function of porcine myocardium subjected to 1 h of low-flow ischemia followed by 2 hr of reperfusion. In that study, ischemia may have been too severe and/or the duration of reperfusion too short to detect a beneficial effect of the compound. Therefore, in the present study we investigated the effects of saline (control group; n = 14) or pretreatment with L-propionyl-carnitine (3 days of 50 mg/kg p.o. b.i.d. + 50 mg/kg i.v. prior to the experiment; n = 13) on recovery of regional contractile function of the myocardium in open-chest anesthetized pigs, subjected to two cycles of 10 min of left anterior descending coronary artery (LADCA) occlusion, each followed by 30 min of reperfusion. In the control animals, at the end of the second reperfusion period, systemic vascular resistance had increased by 18%, which, however, was not observed in the L-propionylcarnitine-treated pigs. In the control group, during the first occlusion, systolic segment length shortening (SSLS) of the LADCA-perfused area decreased from 18.5 +/- 5.5% to -3.7 = 3.2%. After 30 min of reperfusion, SSLS of the LADCA-perfused area had only partially recovered to 6.2 +/- 5.9%. During the second occlusion-reperfusion cycle similar values for SSLS were observed. In the treated animals, SSLS of the LADCA-perfused area was slightly improved after the second occlusion-reperfusion cycle (p = 0.056). This effect did not result in an overall improvement in cardiac pump function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1480143     DOI: 10.1007/bf01270582

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.

Authors:  A Chiddo; A Gaglione; S Musci; G Troito; N Grimaldi; N Locuratolo; P Rizzon
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  Protective effects of propionyl-L-carnitine during ischemia and reperfusion.

Authors:  A Shug; D Paulson; R Subramanian; V Regitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Effect of propionyl-L-carnitine on experimental myocardial infarction in dogs.

Authors:  J E Leasure; K Kordenat
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

4.  Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs.

Authors:  A Cevese; F Schena; G Cerutti
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

5.  Evaluation of parameters for the assessment of regional myocardial contractile function during asynchronous left ventricular contraction.

Authors:  B D Guth; R Schulz; G Heusch
Journal:  Basic Res Cardiol       Date:  1990 Nov-Dec       Impact factor: 17.165

6.  L-propionylcarnitine increases postischemic blood flow but does not affect recovery of energy charge.

Authors:  L M Sassen; K Bezstarosti; W J Van der Giessen; J M Lamers; P D Verdouw
Journal:  Am J Physiol       Date:  1991-07

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.

Authors:  J M Lamers; J T De Jonge-Stinis; P D Verdouw; W C Hülsmann
Journal:  Cardiovasc Res       Date:  1987-05       Impact factor: 10.787

9.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

10.  Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts.

Authors:  A J Liedtke; L DeMaison; S H Nellis
Journal:  Am J Physiol       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.